FDA NDC Directory · JSON-LD · Markdown

CLIGAVYX

NDC 83831-159 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namefulvestrant
Labeler / ManufacturerAvyxa Pharma, LLC
Marketing categoryNew Drug Application (innovator) · App NDA210063
Dosage form / routeINJECTION · INTRAMUSCULAR
Active ingredientsFULVESTRANT (250 mg/5mL)
Marketing started20260701
Package count1

External sources

Source: openFDA. Public-domain (CC0).